VRNA vs. CVD.TO

Last updated Jun 9, 2026

VRNA (Verona Pharma plc) is a stock, while CVD.TO (iShares Convertible Bond Index ETF) is High Yield Bonds fund tracking the FTSE Canada Convertible Bond Index. At a 0.08 correlation, their price movements are largely independent.

Performance

VRNA vs. CVD.TO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and iShares Convertible Bond Index ETF (CVD.TO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

VRNA is traded in USD, while CVD.TO is traded in CAD. To make them comparable, the CVD.TO values have been converted to USD using the latest available exchange rates.

Returns By Period

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CVD.TO

• 1D: -0.55%
• 1M: -1.44%
• YTD: 1.49%
• 6M: 0.09%
• 1Y: 5.70%
• 3Y*: 6.76%
• 5Y*: 1.51%
• 10Y*: 3.56%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VRNA vs. CVD.TO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	-4.00%	21.74%	-40.41%	-18.71%	-12.07%
CVD.TO iShares Convertible Bond Index ETF	1.49%	12.22%	3.88%	6.17%	-10.31%	5.38%	6.19%	15.02%	-10.23%	9.84%

Correlation

The correlation between VRNA and CVD.TO is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (All Time) Calculated using the full available price history since Apr 27, 2017	0.08

Return for Risk

VRNA vs. CVD.TO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CVD.TO

CVD.TO Risk / Return Rank: 37
CVD.TO Sharpe Ratio Rank: 33
CVD.TO Sortino Ratio Rank: 31
CVD.TO Omega Ratio Rank: 37
CVD.TO Calmar Ratio Rank: 44
CVD.TO Martin Ratio Rank: 39

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. CVD.TO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and iShares Convertible Bond Index ETF (CVD.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	VRNA	CVD.TO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.67	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.13	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.30	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.15	—

Drawdowns

Drawdown Indicators

	VRNA	CVD.TO	Difference
Max Drawdown Largest peak-to-trough decline	—	-34.37%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-3.78%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-14.52%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-22.91%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-30.24%	—
Current Drawdown Current decline from peak	—	-3.78%	—
Average Drawdown Average peak-to-trough decline	—	-9.34%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	1.83%	—

Volatility

Volatility by Period

	VRNA	CVD.TO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	1.39%	—
Volatility (6M) Calculated over the trailing 6-month period	—	6.65%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	8.61%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	11.37%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	11.79%	—

Dividends

VRNA vs. CVD.TO - Dividend Comparison

VRNA has not paid dividends to shareholders, while CVD.TO's dividend yield for the trailing twelve months is around 4.94%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CVD.TO iShares Convertible Bond Index ETF	4.94%	4.91%	5.14%	5.33%	5.05%	4.61%	4.48%	4.52%	4.97%	4.65%	4.51%	4.94%
VRNA Verona Pharma plc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both VRNA and CVD.TO in my portfolio?

VRNA and CVD.TO have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.